Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome

J. Ramirez, B. Lectez, N. Osinalde, M. Sivá, N. Elu, K. Aloria, M. Procházková, C. Perez, J. Martínez-Hernández, R. Barrio, KG. Šašková, JM. Arizmendi, U. Mayor,

. 2018 ; 27 (11) : 1955-1971.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012655

Angelman syndrome is a complex neurodevelopmental disorder caused by the lack of function in the brain of a single gene, UBE3A. The E3 ligase coded by this gene is known to build K48-linked ubiquitin chains, a modification historically considered to target substrates for degradation by the proteasome. However, a change in protein abundance is not proof that a candidate UBE3A substrate is indeed ubiquitinated by UBE3A. We have here used an unbiased ubiquitin proteomics approach, the bioUb strategy, to identify 79 proteins that appear more ubiquitinated in the Drosophila photoreceptor cells when Ube3a is over-expressed. We found a significantly high number of those proteins to be proteasomal subunits or proteasome-interacting proteins, suggesting a wide proteasomal perturbation in the brain of Angelman patients. We focused on validating the ubiquitination by Ube3a of Rngo, a proteasomal component conserved from yeast (Ddi1) to humans (DDI1 and DDI2), but yet scarcely characterized. Ube3a-mediated Rngo ubiquitination in fly neurons was confirmed by immunoblotting. Using human neuroblastoma SH-SY5Y cells in culture, we also observed that human DDI1 is ubiquitinated by UBE3A, without being targeted for degradation. The novel observation that DDI1 is expressed in the developing mice brain, with a significant peak at E16.5, strongly suggests that DDI1 has biological functions not yet described that could be of relevance for Angelman syndrome clinical research.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012655
003      
CZ-PrNML
005      
20190411132729.0
007      
ta
008      
190405s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/hmg/ddy103 $2 doi
035    __
$a (PubMed)29788202
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Ramirez, Juanma $u Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
245    10
$a Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome / $c J. Ramirez, B. Lectez, N. Osinalde, M. Sivá, N. Elu, K. Aloria, M. Procházková, C. Perez, J. Martínez-Hernández, R. Barrio, KG. Šašková, JM. Arizmendi, U. Mayor,
520    9_
$a Angelman syndrome is a complex neurodevelopmental disorder caused by the lack of function in the brain of a single gene, UBE3A. The E3 ligase coded by this gene is known to build K48-linked ubiquitin chains, a modification historically considered to target substrates for degradation by the proteasome. However, a change in protein abundance is not proof that a candidate UBE3A substrate is indeed ubiquitinated by UBE3A. We have here used an unbiased ubiquitin proteomics approach, the bioUb strategy, to identify 79 proteins that appear more ubiquitinated in the Drosophila photoreceptor cells when Ube3a is over-expressed. We found a significantly high number of those proteins to be proteasomal subunits or proteasome-interacting proteins, suggesting a wide proteasomal perturbation in the brain of Angelman patients. We focused on validating the ubiquitination by Ube3a of Rngo, a proteasomal component conserved from yeast (Ddi1) to humans (DDI1 and DDI2), but yet scarcely characterized. Ube3a-mediated Rngo ubiquitination in fly neurons was confirmed by immunoblotting. Using human neuroblastoma SH-SY5Y cells in culture, we also observed that human DDI1 is ubiquitinated by UBE3A, without being targeted for degradation. The novel observation that DDI1 is expressed in the developing mice brain, with a significant peak at E16.5, strongly suggests that DDI1 has biological functions not yet described that could be of relevance for Angelman syndrome clinical research.
650    _2
$a Angelmanův syndrom $x genetika $x patofyziologie $7 D017204
650    _2
$a zvířata $7 D000818
650    _2
$a aspartátové proteasy $x genetika $7 D057055
650    _2
$a Drosophila $7 D004330
650    _2
$a proteiny Drosophily $x genetika $7 D029721
650    _2
$a regulace genové exprese $x genetika $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a neurony $x metabolismus $x patologie $7 D009474
650    _2
$a fotoreceptory $x metabolismus $x patologie $7 D010786
650    _2
$a proteomika $7 D040901
650    _2
$a Saccharomyces cerevisiae - proteiny $x genetika $7 D029701
650    _2
$a ubikvitinligasy $x genetika $7 D044767
650    _2
$a ubikvitinace $x genetika $7 D054875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lectez, Benoit $u Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
700    1_
$a Osinalde, Nerea $u Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.
700    1_
$a Sivá, Monika $u Department of Genetics and Microbiology, Charles University, 12843 Prague, Czech Republic. Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic. First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic.
700    1_
$a Elu, Nagore $u Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
700    1_
$a Aloria, Kerman $u Proteomics Core Facility-SGIKER, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
700    1_
$a Procházková, Michaela $u Czech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic.
700    1_
$a Perez, Coralia $u Functional Genomics Unit, CIC bioGUNE, 48160 Derio, Spain.
700    1_
$a Martínez-Hernández, Jose $u Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain. Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.
700    1_
$a Barrio, Rosa $u Functional Genomics Unit, CIC bioGUNE, 48160 Derio, Spain.
700    1_
$a Šašková, Klára Grantz $u Department of Genetics and Microbiology, Charles University, 12843 Prague, Czech Republic. Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic.
700    1_
$a Arizmendi, Jesus M $u Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
700    1_
$a Mayor, Ugo $u Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain. Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.
773    0_
$w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 27, č. 11 (2018), s. 1955-1971
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29788202 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411132747 $b ABA008
999    __
$a ok $b bmc $g 1391965 $s 1050960
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 27 $c 11 $d 1955-1971 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Možnosti archivace